Cardiff Oncology Statistics
Total Valuation
CRDF has a market cap or net worth of $159.80 million. The enterprise value is $90.56 million.
Important Dates
The last earnings date was Tuesday, July 29, 2025, after market close.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CRDF has 66.53 million shares outstanding. The number of shares has increased by 30.91% in one year.
| Current Share Class | 66.53M |
| Shares Outstanding | 66.53M |
| Shares Change (YoY) | +30.91% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 2.45% |
| Owned by Institutions (%) | 41.81% |
| Float | 59.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 263.16 |
| Forward PS | 483.64 |
| PB Ratio | 2.78 |
| P/TBV Ratio | 2.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 166.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.42, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.42 |
| Quick Ratio | 4.29 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -91.93% and return on invested capital (ROIC) is -59.56%.
| Return on Equity (ROE) | -91.93% |
| Return on Assets (ROA) | -47.90% |
| Return on Invested Capital (ROIC) | -59.56% |
| Return on Capital Employed (ROCE) | -91.98% |
| Revenue Per Employee | $16,515 |
| Profits Per Employee | -$1.55M |
| Employee Count | 33 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.41% in the last 52 weeks. The beta is 1.54, so CRDF's price volatility has been higher than the market average.
| Beta (5Y) | 1.54 |
| 52-Week Price Change | +8.41% |
| 50-Day Moving Average | 3.46 |
| 200-Day Moving Average | 3.44 |
| Relative Strength Index (RSI) | 35.13 |
| Average Volume (20 Days) | 3,211,413 |
Short Selling Information
The latest short interest is 18.84 million, so 28.32% of the outstanding shares have been sold short.
| Short Interest | 18.84M |
| Short Previous Month | 18.90M |
| Short % of Shares Out | 28.32% |
| Short % of Float | 31.66% |
| Short Ratio (days to cover) | 7.01 |
Income Statement
In the last 12 months, CRDF had revenue of $545,000 and -$51.04 million in losses. Loss per share was -$0.87.
| Revenue | 545,000 |
| Gross Profit | -40.86M |
| Operating Income | -54.33M |
| Pretax Income | -40.86M |
| Net Income | -51.04M |
| EBITDA | -53.95M |
| EBIT | -54.33M |
| Loss Per Share | -$0.87 |
Full Income StatementBalance Sheet
The company has $70.96 million in cash and $1.19 million in debt, giving a net cash position of $69.77 million or $1.05 per share.
| Cash & Cash Equivalents | 70.96M |
| Total Debt | 1.19M |
| Net Cash | 69.77M |
| Net Cash Per Share | $1.05 |
| Equity (Book Value) | 58.61M |
| Book Value Per Share | 0.88 |
| Working Capital | 57.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$41.85 million and capital expenditures -$26,000, giving a free cash flow of -$41.87 million.
| Operating Cash Flow | -41.85M |
| Capital Expenditures | -26,000 |
| Free Cash Flow | -41.87M |
| FCF Per Share | -$0.63 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -9,969.17% |
| Pretax Margin | -9,361.28% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRDF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.91% |
| Shareholder Yield | -30.91% |
| Earnings Yield | -31.84% |
| FCF Yield | -26.12% |
Analyst Forecast
The average price target for CRDF is $10.58, which is 340.47% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.58 |
| Price Target Difference | 340.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 20, 2019. It was a reverse split with a ratio of 1:6.
| Last Split Date | Feb 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
CRDF has an Altman Z-Score of -2.61 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.61 |
| Piotroski F-Score | 1 |
